Who Paid My Doc
Todd Mollet
MOHS-Micrographic Surgery Oklahoma City, OK Medical Doctor
NPI 1174843296 CMS profile 325442
13100 N Western Ave Ste 301, Oklahoma City, OK 73114
General payments
$808
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Todd Mollet of Oklahoma City, OK is reported in the CMS Open Payments database as having received $808 across 46 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 33rd percentile of MOHS-Micrographic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $145 | 13 | |
| 2024 | General | $84 | 3 | |
| 2023 | General | $39 | 2 | |
| 2022 | General | $259 | 12 | |
| 2021 | General | $108 | 7 | |
| 2020 | General | $37 | 2 | |
| 2019 | General | $138 | 7 |
Beside peers
- Todd Mollet
- MOHS-Micrographic Surgery median
- Middle half of MOHS-Micrographic Surgery
- National median
In program year 2025, general payments to Todd Mollet were reported at $145. Among 1,077 MOHS-Micrographic Surgery profiles paid that year, the median was $465 and the middle half received between $145 and $1,066.
Show as a table
| Year | Todd Mollet | MOHS-Micrographic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $138 | $316 | $106–$785 | $163 |
| 2020 | $37 | $162 | $68–$412 | $114 |
| 2021 | $108 | $243 | $87–$654 | $132 |
| 2022 | $259 | $300 | $102–$887 | $149 |
| 2023 | $39 | $364 | $125–$1,010 | $160 |
| 2024 | $84 | $445 | $142–$1,108 | $164 |
| 2025 | $145 | $465 | $145–$1,066 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
1,900
Drug cost
$7,983
Branded share of claims
41.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Cephalexin | Generic | 832 | $3,349 | |
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 752 | $2,619 | |
| Minocycline Hcl | Generic | 196 | $1,573 | |
| Doxycycline Hyclate | Generic | 15 | $141 | |
| Tramadol Hcl | Generic | 61 | $120 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 30 | $94 | |
| Ciprofloxacin Hcl | Generic | 14 | $85 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 89 billing codesPaid by Medicare
$1,535,719
Medicare patients
745
Services billed
5,047
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 45% | |
| Ischemic heart disease | 39% | |
| Diabetes | 30% | |
| Chronic kidney disease | 30% | |
| Atrial fibrillation | 18% | |
| Cancer | 17% | |
| Depression | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Novachor, per square centimeter Q4194 | Office | 29 | 826 | $654,049 |
| Puraply xt, per square centimeter Q4197 | Office | 19 | 1,200 | $102,458 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
46 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other MOHS-Micrographic Surgery in Oklahoma
Carlos Garcia
MOHS-Micrographic Surgery · Oklahoma City, OK
Travis Blalock
MOHS-Micrographic Surgery · Oklahoma City, OK
Robert Fischer
MOHS-Micrographic Surgery · Tulsa, OK
Carlos Gomez-Meade
MOHS-Micrographic Surgery · Broken Arrow, OK
Jason Hirshburg
MOHS-Micrographic Surgery · Oklahoma City, OK
Mary Christian Reed
MOHS-Micrographic Surgery · Tulsa, OK
Related records
MOHS-Micrographic Surgery in Oklahoma
Practitioners in the same specialty and state, ranked by reported value.
All MOHS-Micrographic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Oklahoma
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.